Regenerative Medicine Regenerative Medicine: A Holistic Approach for Musculoskeletal & Peripheral Vascular Disorders
That regenerative medicine is a holistic practice implies that regenerative medicine techniques for musculoskeletal and peripheral vascular disorders are both available and effective. That is true. Adding a holistic approach is another step in the process that helps your body move forward on a healing path.
Numerous forms of regenerative medicine exist. From a musculoskeletal and peripheral vascular perspective the first step should embrace the importance of nutrition. While several procedures are available to enhance cell regeneration none of them will be as effective if the body is nutritionally deficient. While numerous supplements are available, we recommend Juice Plus. This is a whole food fruits and vegetable extract with several medical school studies that demonstrate Juice Plus absorption and cell integration of the underlying nutrients.
Before regenerative medicine techniques are initiated it is best to have a medical doctor evaluate the root cause of the problem. Often underlying conditions are present that affect healing. For example, a patient with diabetes or early peripheral arterial disease will not heal as quickly as someone without those conditions. Medical management to obtain optimal control of co morbid disease can only enhance a regenerative medicine approach.
Likewise a torn rotator cuff in the shoulder or an osteoarthritic knee may be associated with a strained ligament in the neck or a nerve irritation in the low back. Quite often treating the spinal component will improve the results of treating the injured limb. That means the whole body should be evaluated, not just the area of most obvious interest. If muscles are inhibited, tight or weak a functional restoration program to re educate, stretch and then strengthen should occur.
Diagnostic Musculoskeletal Ultrasound, Segmental Plethysmography, and Arterial Duplex studies are three non invasive and non ionizing tests that can both image and detect the presence of injury or disease. Depending upon the severity of findings results can be used to formulate a focused treatment plan. A very powerful tool to re-grow, or proliferate torn or stretched muscle, tendon and ligament is Prolotherapy.
Prolotherapy is a technique where medications are injected into an injured musculoskeletal body part with the intent of regenerating tissue. Various compounds are used, but we prefer a combination of Xylocaine and Sodium Morrhuate. Morruate is 80% arachandonic acid. When injected into the injured body part it stimulates local prostaglandin production, which in turn initiates the wound healing cascade.
Essentially Prolotherapy is a natural way of telling your bodys natural wound healing response to come to an area and to it. Injections are often done an average of three times over a several weeks. Biopsies have been done and confirm the creation of organized tissue (not scar formation). After the third injection a 40% thickening can be expected.
For more severe cases, or in instances where a faster response is needed, PRP can be done. In this instance Platelet Rich Plasma (concentrated growth factors from your own blood) are injected into the injured tissue. Unlike prolotherapy that tells your bodys natural wound healing response to come to an area, PRP concentrates those cells involved in wound healing and puts them into the area. Usually only one or two injections are needed. While there can be more pain right after the injection it is usually short lived and followed by rapid improvement.
Placed in between PRP and Stem Cell therapy are concentrated growth factors that are obtained from donor sources such as amnion (the inner most layer of the placenta) or from the placenta itself. When tissue or growth factors are obtained from sources other then your own body they are called allografts. While some biologic companies that provide placenta derived growth factors have studies that show their products contain stem cells most claims from this class of products are restricted to containing growth factors only. The FDA closely monitors the process whenever biologics such as these are used to help assure that strict safety standards are met. Nice things about allograft growth factor treatments include relative ease of administration, they usually only need to be done one time, and they cause little pain during the procedure.
Even more advanced regenerative techniques include obtaining stem cells from bone marrow or fatty tissue (when the cells come from your own body they are referred to as autologus grafts), or umbilical cord derived sources. The goal for both autologus and allograft stem cell therapy is to provide a high concentration of undifferentiated cells (cells that have not yet decided what they want to be). Harvesting and preparing stem cells from bone marrow or fat cells requires a minor surgical procedure (either bone marrow aspiration or liposuction) so the technology needed to obtain these cells, and then to concentrate them, is more involved for the patient versus getting cells from allograft sources. That also means that the cost for autologus stem cells is higher and there is generally some pain when the tissue is taken (in most cases this is well controlled however some discomfort should be expected). When stem cells come from other donors as is the case with umbilical cord derived sources there is little or no pain associated with the procedure since only a graft is required. With each step up from proliferative injections to stem cell treatment the cost is higher and the response is expected to be more robust.
It is readily accepted that PRP and Stem Cell therapies can regenerate ligament and facilitate muscle & tendon healing. Cartilage restoration is a bit more controversial. Most physicians that perform regenerative medicine treatments however agree that when stem cells are employed the clinical response looks very much like new cartilage was laid down. With the exception of select cancer and wound or peripheral vascular conditions while there have been exciting reports of stem cell treatments resulting in miraculous responses in a wide range of medical conditions for the most part these other indications are not yet readily accepted by the medical community. Our office has published in the past on reversal of peripheral vascular disease when nutritional support (Juice Plus) is combined with medications such as Plavix and Pletal. We have seen excellent responses in wound and peripheral vascular cases using PRP or Stem Cell this approach in our opinion they are still not the main stay of treatment and experience remains anecdotal.
Reducing total load means doing whatever is necessary to put the body back onto a healing path. In an effort to maximize outcomes we like to help you and your body do what ever is necessary to facilitate the best outcome. That means looking at all the factors that affect wellness and doing whatever else is necessary too support your musculoskeletal system and the joint or tissue we are trying to treat. Some patients may even benefit from treatment with hormone replacement therapy, infectious and immunological approaches, or addressing mind body spirit challenges. We try to be open minded in our approach and provide only those treatments that make sense for you. Whether you suffer from sprained, strained or partially torn muscle, tendon, ligament, or have joint space narrowing associated with osteoarthritis,regenerative medicine offers new treatment options for restoring quality of life.
Read the rest here:
Regenerative Medicine Treatment in Greenville, Spartanburg ...
- Stem Cells Applications in Regenerative Medicine and Disease ... - December 6th, 2024
- Ageing of stem cells reduces their capacity to form tumours - Nature.com - December 6th, 2024
- Master of Science in Regenerative Medicine and Entrepreneurships FUSION program information session - The Daily | Case Western Reserve University - December 6th, 2024
- BioRestorative Therapies Announces Notice of Allowance of - GlobeNewswire - December 6th, 2024
- Stem Cell Therapy Strategic Business Report 2024 - - GlobeNewswire - December 6th, 2024
- University of Colorado Anschutz Medical Campus-Led Team Receives Up to $46 Million to Develop Innovative Treatment to Cure Blindness - University of... - December 6th, 2024
- Affimed Announces Acimtamig and AlloNK Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug... - December 6th, 2024
- Navigating the hope and hype of regenerative medicine - October 14th, 2024
- Cell and Gene Therapy Investment Ticks Up After Hard Few Years - BioSpace - October 14th, 2024
- Crackdowns on Unproven Stem Cell Therapies Worked Abroad - Medpage Today - October 14th, 2024
- How Regenerative Medicine can help you get out of pain without surgery - WJLA - October 14th, 2024
- Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care... - October 14th, 2024
- Buy, Sell, Hold: Cell and Gene Therapy - BioPharm International - October 14th, 2024
- Mayo Clinic offers unique regenerative medicine procedure for knee and ... - September 13th, 2024
- Regenerative Medicine to the Rescue - Cleveland Clinic - September 13th, 2024
- Regenerative medicine applications: An overview of clinical trials - September 13th, 2024
- The Progression of Regenerative Medicine and its Impact on Therapy ... - September 13th, 2024
- Immune cell injection significantly boosts healing of bone, muscle & skin - September 13th, 2024
- Regenerative Medicine Foundation - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT ... - September 13th, 2024
- Tissue engineering and regenerative medicine approaches in colorectal ... - September 13th, 2024
- Tubular scaffolds boost stem cell-driven bone regeneration in skull defects - Phys.org - September 13th, 2024
- Finding the right path(way) to reduce fat accumulation in the liver - Medical University of South Carolina - September 13th, 2024
- NAMRU EURAFCENT Signs Agreement with Egypt Center for Research and Regenerative Medicine - DVIDS - September 13th, 2024
- BridgeBio Receives FDAs Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program - StockTitan - September 13th, 2024
- BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and... - September 13th, 2024
- Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate - Yahoo Finance - September 13th, 2024
- Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets - Nature.com - September 13th, 2024
- Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H) - Business Wire - September 13th, 2024
- HepaTx Enters Collaboration with Mayo Clinic to Advance Cell Therapy Technology for Liver Disease to Clinical Trials - Longview News-Journal - September 13th, 2024
- Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma -... - September 4th, 2024
- Regenerative Medicine in Orthopedic Surgery: Expanding Our Toolbox - Cureus - September 4th, 2024
- Somite.ai takes pre-seed to $10M as it eyes to become the OpenAI of stem cell biology - CTech - September 4th, 2024
- Longeveron Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B in Hypoplastic Left Heart Syndrome (HLHS) - Yahoo... - September 4th, 2024
- Study Explores Potential Of 3D Printed Regenerative Breast Implants - Forbes - September 4th, 2024
- Nikon Announces New Image Analysis Functions to Empower Drug Discovery Research for Cancer, Neurological Disease, and Regenerative Medicine - PR... - September 4th, 2024
- Trinity researcher scores 800,000 to boost regenerative medicine - SiliconRepublic.com - September 4th, 2024
- Seeing the future: Zebrafish regenerates fully functional photoreceptor cells and restores its vision - EurekAlert - September 4th, 2024
- Regenerative Medicine Industry Projected to Surge to USD 73,084.2 Million by 2033, Growing at an 18.5% CAGR - Future Market Insights - September 4th, 2024
- What is regenerative medicine? | Northwell Health - July 2nd, 2024
- Science Saturday: A regenerative reset for aging - July 2nd, 2024
- Science Saturday: A year of new directions and advancements for ... - March 29th, 2024
- Diverse ways regenerative medicine is advancing health care - March 29th, 2024
- Stem cell-based regenerative medicine - PMC - National Center for ... - February 27th, 2024
- Regenerative medicine | NIST - February 10th, 2024
- San Jose blood stem cell donor meets 15-year-old whose life he saved in Los Angeles - The Mercury News - May 17th, 2023
- Regenerative medicine: Current therapies and future directions - April 23rd, 2023
- What Is Regenerative Medicine? | Goals and Applications | ISCRM - April 23rd, 2023
- Important Patient and Consumer Information About Regenerative Medicine ... - April 23rd, 2023
- Regenerative medicine can be a boon for those with Drug-Resistant Tuberculosis - Hindustan Times - April 23rd, 2023
- About Regenerative Medicine - Center for Regenerative ... - Mayo Clinic - April 7th, 2023
- Regenerative Medicine | National Institutes of Health (NIH) - April 7th, 2023
- Porcine Vaccine Market is estimated to be US$ 4.41 billion by 2030 with a CAGR of 7.50%during the forecast - EIN News - April 7th, 2023
- Advancing Safe and Effective Regenerative Medicine Products - March 21st, 2023
- Active Wound Care Market Rising demand for Skin Substitutes to boost the industry (2023-2033) | CAGR of 5.5% - EIN News - March 21st, 2023
- Veterinary Orthopedic Implants Market is estimated to be 421.3 Million by 2029 with a CAGR of 5.3% - By PMI - EIN News - March 21st, 2023
- ASKA Pharmaceutical : February 7 2023 EME and ASKA Announce Collaboration Agreement on Creating Novel PharmaLogical VHH to address an unmet medical... - February 8th, 2023
- A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field - Yahoo Finance - October 15th, 2022
- The Switch to Regenerative Medicine - Dermatology Times - October 15th, 2022
- The Alliance for Regenerative Medicine Announces Election of 2023 Officers, Executive Committee, and Board of Directors - GlobeNewswire - October 15th, 2022
- Mathematical model could bring us closer to effective stem cell therapies - Michigan Medicine - October 15th, 2022
- 'We have to find a way': FDA seeks solutions to aid bespoke gene therapy - BioPharma Dive - October 15th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - GlobeNewswire - October 15th, 2022
- Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022 -... - October 15th, 2022
- The Risk-Reward Proposition for CGT Clinical Trials - Applied Clinical Trials Online - October 15th, 2022
- Cell therapy weekly: Ray Therapeutics and Forge Biologics expand partnership - RegMedNet - October 15th, 2022
- FDA Expands Oversight of Cell and Gene Therapies - Pharmaceutical Technology Magazine - October 15th, 2022
- Frequency Therapeutics Completes Enrollment of Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss - Business Wire - October 15th, 2022
- The Health Benefits Of Sea Moss, According To Experts - Forbes - October 15th, 2022
- ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of ... - The Bakersfield Californian - October 15th, 2022
- Pain Management & Regenerative Medicine Specialists DFW - September 4th, 2022
- Tissue Engineering and Regenerative Medicine - National Institute of ... - September 4th, 2022
- First U.S. patient receives autologous stem cell therapy to treat dry AMD - National Institutes of Health (.gov) - September 4th, 2022
- International Stem Cell and Regenerative Medicine Research and Therapeutic Center in Egypt - Construction Review - September 4th, 2022
- Regenerative Medicine Market to Garner Bursting Revenues [+USD 27.29 Billion] with Top Growing Companies During 2022-2029 - eTurboNews | eTN - September 4th, 2022
- Immusoft Takes First-Ever Engineered B Cell Therapy into Clinic - BioSpace - September 4th, 2022
- Addressing Diversity Barriers to Regenerative Medicine Free Press of Jacksonville - Jacksonville Free Press - September 4th, 2022
- TikoMed's ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all... - September 4th, 2022
- Frequency Therapeutics to Participate in September Investor and Medical Conferences - Business Wire - September 4th, 2022
- Can the immortal jellyfish teach us how to reverse aging? - Earth.com - September 4th, 2022